Breast cancer incidence and hormone therapy use before and after the Women's Health Initiative (WHI) estrogen (E) plus progestin (P) trial by race/ethnicity

被引：0
|
作者：
Chlebowski, Rowan T. [1 ]
Aragaki, Aaron K. [2 ]
Anderson, Garnet L. [2 ]
Prentice, Ross L. [2 ]
机构：
[1] Harbor UCLA Med Ctr, Torrance, CA 90509 USA
[2] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-LB-170
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB-170
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women’s Health Initiative Hormone Trial
    K. L. Margolis
    D. E. Bonds
    R. J. Rodabough
    L. Tinker
    L. S. Phillips
    C. Allen
    T. Bassford
    G. Burke
    J. Torrens
    B. V. Howard
    Diabetologia, 2004, 47 : 1175 - 1187
  • [32] Conduct of the Women's Health Initiative randomised trial evaluating estrogen plus progestin: implications for breast cancer findings: authors' response
    Shapiro, Samuel
    Farmer, Richard D. T.
    Stevenson, John C.
    Burger, Henry G.
    JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE, 2013, 39 (03): : 228 - 229
  • [33] Effect of estrogen plus progestin on stroke in postmenopausal women - The Women's Health Initiative: A randomized trial
    Wassertheil-Smoller, S
    Hendrix, SL
    Limacher, M
    Heiss, G
    Kooperberg, C
    Baird, A
    Kotchen, T
    Curb, JD
    Black, H
    Rossouw, JE
    Aragaki, A
    Safford, M
    Stein, E
    Laowattana, S
    Mysiw, WJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (20): : 2673 - 2684
  • [34] Economic Return From the Women's Health Initiative Estrogen Plus Progestin Clinical Trial
    Roth, Joshua A.
    Etzioni, Ruth
    Waters, Teresa M.
    Pettinger, Mary
    Rossouw, Jacques E.
    Anderson, Garnet L.
    Chlebowski, Rowan T.
    Manson, JoAnn E.
    Hlatky, Mark
    Johnson, Karen C.
    Ramsey, Scott D.
    ANNALS OF INTERNAL MEDICINE, 2014, 160 (09) : 594 - U128
  • [35] Colorectal Cancer in Relation to Postmenopausal Estrogen and Estrogen Plus Progestin in the Women's Health Initiative Clinical Trial and Observational Study
    Prentice, Ross L.
    Pettinger, Mary
    Beresford, Shirley A. A.
    Wactawski-Wende, Jean
    Hubbell, F. Allan
    Stefanick, Marcia L.
    Chlebowski, Rowan T.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (05) : 1531 - 1537
  • [36] Fracture risk after estrogen plus progestin discontinuation: The women's health initiative.
    Jackson, RD
    Watts, NB
    Caralis, P
    Cauley, JA
    Chen, Z
    Greep, N
    LaCroix, AZ
    Lewis, CE
    Mouton, CP
    Neuner, JM
    O'Sullivan, MJ
    Robbins, JA
    Sato, A
    Stefanick, ML
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S27 - S27
  • [37] Non-small cell lung cancer and estrogen plus progestin use in postmenopausal women in the Women's Health Initiative randomized clinical trial
    Chlebowski, R. T.
    Schwartz, A.
    Wakelee, H.
    Anderson, G. L.
    Stefanick, M. L.
    Manson, J. E.
    Chien, J. W.
    Chen, C.
    Wactawski-Wende, J.
    Gass, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (18)
  • [38] Hormone therapy prevalence rates in US women 7 years after publication of the Women's Health Initiative (WHI) trial
    Steinkellner, Amy
    Bowlin, Steve
    Denison, Shannon
    Eldridge, Sandi
    Lenzi, Lisa
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2010, 17 (06): : 1242 - 1243
  • [39] Non-small cell lung cancer and estrogen plus progestin use in postmenopausal women in the Women's Health Initiative randomized clinical trial
    Chlebowski, R. T.
    Schwartz, A.
    Wakelee, H.
    Anderson, G. L.
    Stefanick, M. L.
    Manson, J. E.
    Chien, J. W.
    Chen, C.
    Wactawski-Wende, J.
    Gass, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [40] What pharmacists need to know about the Women's Health Initiative Estrogen plus Progestin trial
    Saseen, JJ
    Hansen, LB
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2003, 60 (03) : 281 - 284
12345